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Introduction
The medical plant Rhodiola rosea (roseroot, golden root) is known as a stimulant of mental and 
physical endurance, increasing resistance to chemical, biological, psychological and physical stressors 
(Panossian et al. 2010). Extracts of R. rosea roots contain ﬂavonoids, phenolic acids, phenylethanol 
derivatives (e.g. salidroside) and phenylpropanoid glycosides (e.g. rosavin) (Ioset et al. 2011). Many 
of these compounds are considered potent antioxidants with putative neuroprotective potential  (e.g. 
salidroside (Shi et al. 2011)), but the significance of the various substances for the beneficial effects 
of Roseroot is still largely unknown. Here we tested the neuroprotective effects of crude methanolic 
extracts of R. rosea as well as chemical fractions and/or purified compounds (e.g. salidrosid, rosavin) 
against excitotoxicity and ischemia-like brain damage using organotypic hippocampal slice cultures.  
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Materials & Methods
Crude methanolic extracts of R. rosea roots and ﬂowers (Clone 5, Pharmaplant, Germany, grown for four years in our 
horticulture facilities), as well as chemical fractions of this extract (Table 1) were prepared and partly analysed by LC-MS. 
Hippocampal slice cultures derived from 8 days old rat pups were grown at 33oC in serum-optimum for 2-3 weeks before 
exposure to N-methyl-D-aspartate  (NMDA, 10 µM, 24 or 48 h) or oxygen-glucose deprivation (OGD, 30 or 35 min) at 36oC 
(Noraberg et al. 2005), with and without MK801, Rhodiola rosea extracts or single consitutuents (e.g. rosavin, salidroside) 
before (24 h), during (35 min) and/or immediately after the insult (for 48 h). 
NMDA- or OGD-induced neuronal cell death was quantified by propidium iodide uptake and immunohistochemical staining 
of MAP2 as a neuronal marker. 
Statistics: *) p<0.05, **)p<0.01 ,***p<0.001 One–way ANOVA with Benferroni’s multiple comparison test versus NMDA or 
OGD (day 1 and day 2)
Results
Significant, dose-dependent protection against NMDA and OGD-induced CA1 pyramidal cell death 
was obtained by crude methanolic extracts of Roseroot (roots or ﬂowers) using 250 μg/ml (33-50% 
protection) or 500 µg/ml (45-65% protection) (Figures 3, 4, 5).
A number of chemical fractions of methanolic Rhodiola extracts, as well as the purified constituents 
salidrosid and rosavin were tested, but – so far – none of the tested fractions or single constituents 
showed protection against NMDA or OGD (Table 1).
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Conclusion and perspectives
Methanolic extracts of Rhodiola rosea provide potent neuroprotection against excitotoxic (NMDA) or 
ischemic (OGD) cell death in hippocampal slice cultures.
The active compounds are probably found in fractions A and/or H (table 1), which will be further 
characterized by LC-MS and re-tested in slice cultures.  
We are currently analyzing micro array microRNA and gene analyses data of Roseroot treated cultures 
and peforming Western blotting for selected proteins.
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Figure 1.  Hippocampal slice culture method 
Figure 2.   Experimental protocol  and propidium iodide (PI)  uptake method for quantifying NMDA or OGD-induced cell 
death and neuroprotection by MK801 or R. rosea extract.
Table 1. Testing fractions of Rhodiola rosea extracts* 
Fraction % of whole extract Compounds present Dose range tested Neuroprotection in 
NMDA model
Neuroprotection in 
OGD model
A ? Flavonoids 1-100 µg/ml, BUT: in-
soluble in medium
Not known Not known
B 3.0% Not known 1-100 µg/ml No
C 4.3% Not known 1-100 µg/ml No
D 3.5% Not known 1-100 µg/ml No
E 5.4% Not known 2-200 µg/ml No
F 5.3% Rosavin 2-200 µg/ml No
G 2.6% Rosavin 1-100 µg/ml No
H 76.5% Salidroside, Tyrosol Not tested yet Not known Not known
Pooled fractions B-G Ca. 24% 20-100 µg/ml No No
Single compound Rosavin 10-100 µM No
Single compound Salidroside 10-100 µM No
* The methanol extract was subjected to bioassay-guided chromatographic fractionation by ﬂash column chromatography using a dichloromethane–
methanol gradient resulting in 8 fractions (A–H). Extract and fractions were analyzed by LC-MS for identification of the bioactive compounds in the 
different fractions.
Figure 3.  A. Cell death in CA1 quantified by PI uptake at day 1 (first bar) and day 2 (second bar) after NMDA treatment (10 µM) and protection 
by co-treatment with MK801 or Roseroot (root) extracts (for protocol see figure 2). N=14-18 cultures for each group. 
B. Comparison of ﬂower versus root extracts assessed at day 1 after treatments. N=16-41 for each group. 
Figure 4.  A. Cell death in CA1 quantified by PI uptake at day 1 (first bar) and day 2 (second bar) after OGD treatment (35 min) and protection by 
pre, co- and/or post-treatment with Roseroot (root) extracts  N= 10 for controls, 28 for OGD, 12-17 cultures for Roseroot treatments. 
B. Protection against OGD by MK801 (N=13) and Roseroot extract (N=7-8), but not by rosavin (3 µM) / salidroside (1 µM) (N=5). N= 13 for controls, 10 
for OGD, 14 for OGD+DMSO.
Figure 5.  Representative MAP2 immunohistochemical staining of cryostat-cut sections (20 µM) of hippocampal slice cultures of controls, OGD 
and OGD + Roseroot extract (250 µg/ml) co-treated cultures, fixated 24 h after OGD. 
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